6DECEMBER - JANUARYTECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe pharmaceutical industry is characterized by years-long R&D cycles, as well as an acute need for speed when it comes to time-to-market. As a result, traditionally sales force automation and other back-office automation services have been the main money earners when it comes to pharma outsourcing.The advent of robotic process automation (RPA) in their field of pharmaceutical R&D and manufacturing promises to change the game, as using digital robots to perform high-volume and repeatable tasks, CROs and CMOs can execute recurring processes faster, and more efficiently. This is further accentuated by the fact that RPA solutions are easily implemented without impacting IT-managed infrastructure or technology resources, thereby saving companies considerable time and money while outsourcing.To put the spotlight on such key developments in the industry, Pharma Tech Outlook APAC illustrates how CMOs and CROs are changing the pharma outsourcing space. This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Nick Thomson, Senior Director, Chemical Research and Development, Pfizer Inc; Dr. Sarah Tregenza PhD, BSc (Hons), APAC Oncology Medical Affairs Director, Pierre Fabre; and Dannarjaya Harinta Sri, VP Operations and Technology, PT Anugerah Pharmindo Lestari (APL). In this edition of Pharma Tech Outlook, we also bring to you the story of the top pharma outsourcing companies in the APAC region developing innovative products such as non-monoclonal antibodies, novel small molecule drugs, and specialty injectables. In the list, Alithia LIfe Sciences stands out for offering clinical research consulting including feasibility, selection, and support of vendors, sites, and CROs to undertake a client's project.Through the following pages, we aim to shine a light on the innovative trends and latest developments in the pharma outsourcing space. We would like to know your thoughts.Connecting CMOs, CROs, and Pharmaceuticals Copyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - JANUARY, Vol 08 - Issue 20 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerPresley MeadowMichael WayneEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul Barbersales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:TECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >